Skip to main content

Table 1 Patient characteristics in the radical prostatectomy (n = 202)

From: Preoperative imaging accuracy in size determination of prostate cancer in men undergoing radical prostatectomy for clinically localised disease

Patients (N)

202

Age (LRP year)

 

 Median (IQR*)

67.0 (64–71)

PSA level (ng/mL)

 

 Median (IQR)

9.4 (7.3–13.5)

Prostate Weight (mL)

 

 Median (IQR)

60.0 (47.1–78.5)

PSAD (ng/mL2)

 

 Median (IQR)

0.2 (0.2–0.1)

 Gleason score

n (%)

 3 + 3

7 (3.0)

 3 + 4

101 (48.0)

 4 + 3

35 (17.0)

 3 + 5

21 (10.0)

 4 + 4

3 (1.0)

 4 + 5 or more

45 (21.0)

 pT stage

n (%)

 pT2a

11 (5.0)

 pT2b

3 (1.0)

 pT2c

106 (50.0)

 pT3a

67 (32.0)

 pT3b

23 (11.0)

 pT4

2 (1.0)

 Lymph node status

n (%)

 pN0

187 (88.0)

 pN1

13 (6.0)

 pNX

12 (6.0)

 PIRADS

n (%)

 3

16 (7.6)

 4

59 (27.8)

 5

137 (64.6)

  1. *IQR, interquartile range; ^PSA, prostatic specific antigen; &PSAD, prostatic specific antigen density